惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园_首页
博客园 - Franky
大猫的无限游戏
大猫的无限游戏
博客园 - 三生石上(FineUI控件)
量子位
博客园 - 聂微东
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
S
SegmentFault 最新的问题
Apple Machine Learning Research
Apple Machine Learning Research
爱范儿
爱范儿
V
Visual Studio Blog
雷峰网
雷峰网
T
Tailwind CSS Blog
宝玉的分享
宝玉的分享
Blog — PlanetScale
Blog — PlanetScale
有赞技术团队
有赞技术团队
博客园 - 叶小钗
Microsoft Azure Blog
Microsoft Azure Blog
T
The Blog of Author Tim Ferriss
U
Unit 42
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
小众软件
小众软件
阮一峰的网络日志
阮一峰的网络日志
Y
Y Combinator Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call...
SA Transcripts · 2026-05-05 · via All Articles on Seeking Alpha

Q2: 2026-05-04 Earnings Summary

EPS of -$0.60 misses by $0.07

 | 

Revenue of

$110.72M

(19.31% Y/Y)

beats by $3.05M

Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call May 4, 2026 8:00 AM EDT

Company Participants

Angela Bitting - Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs
Emily Leproust - Co-Founder, Board Chair & CEO
Patrick Finn - President & COO
Adam Laponis - Chief Financial Officer

Conference Call Participants

Steven Etoch - Stephens Inc., Research Division
Vijay Kumar - Evercore ISI Institutional Equities, Research Division
Douglas Schenkel - Wolfe Research, LLC
Luke Sergott - Barclays Bank PLC, Research Division
Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division
Matthew Larew - William Blair & Company L.L.C., Research Division
Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division
Michael Almisry - Leerink Partners LLC, Research Division
Brendan Smith - TD Cowen, Research Division
Tom DeBourcy - Nephron Research LLC

Presentation

Operator

Welcome to Twist Bioscience's 2026 Second Quarter Financial Results Conference Call. [Operator Instructions] Also note, this call is being recorded.

I would now like to turn the call over to Angela Bitting, SVP of Corporate Affairs. Please go ahead.

Angela Bitting
Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs

Thank you, operator. Good morning, everyone. I would like to thank you for joining us for Twist Bioscience's conference call to review our fiscal 2026 second quarter financial results and business progress. We issued our financial results press release before the market, and it is available at our website at www.twistbioscience.com. With me on the call today are Dr. Emily Leproust, CEO and Co-Founder of Twist; Adam Laponis, CFO of Twist; and Dr. Patrick Finn, President and COO of Twist.

Today, we will discuss our business progress, financial and operational performance as well as growth opportunities. We will then open the call for questions. We ask that you limit your questions to only one and then requeue as a courtesy to others on the call. This call is being recorded. The